Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.84 EUR
−77.82 M EUR
0.00 EUR
108.05 M
About Viking Therapeutics, Inc.
Sector
CEO
Brian Lian
Headquarters
San Diego
Website
Founded
2012
FIGI
BBG008MYSTS9
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange VIKING THERAPEUT.DL -,005 stocks are traded under the ticker 1VT.
We've gathered analysts' opinions on VIKING THERAPEUT.DL -,005 future price: according to them, 1VT price has a max estimate of 155.55 EUR and a min estimate of 75.88 EUR. Watch 1VT chart and read a more detailed VIKING THERAPEUT.DL -,005 stock forecast: see what analysts think of VIKING THERAPEUT.DL -,005 and suggest that you do with its stocks.
Yes, you can track VIKING THERAPEUT.DL -,005 financials in yearly and quarterly reports right on TradingView.
VIKING THERAPEUT.DL -,005 is going to release the next earnings report on Feb 5, 2025. Keep track of upcoming events with our Earnings Calendar.
1VT earnings for the last quarter are −0.20 EUR per share, whereas the estimation was −0.22 EUR resulting in a 9.42% surprise. The estimated earnings for the next quarter are −0.27 EUR per share. See more details about VIKING THERAPEUT.DL -,005 earnings.
VIKING THERAPEUT.DL -,005 revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
1VT net income for the last quarter is −22.40 M EUR, while the quarter before that showed −20.77 M EUR of net income which accounts for −7.83% change. Track more VIKING THERAPEUT.DL -,005 financial stats to get the full picture.
No, 1VT doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 30, 2024, the company has 27.00 employees. See our rating of the largest employees — is VIKING THERAPEUT.DL -,005 on this list?
Like other stocks, 1VT shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VIKING THERAPEUT.DL -,005 stock right from TradingView charts — choose your broker and connect to your account.